June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Downregulation of TNFRSF10A promotes RPE cell death via PKC deactivation
Author Affiliations & Notes
  • Kenichiro Mori
    Ophthalmology, Kyushu University, Graduate School of Medical Sciences, Fukuoka, Japan
  • Keijiro Ishikawa
    Ophthalmology, Kyushu University, Graduate School of Medical Sciences, Fukuoka, Japan
  • Iori Wada
    Ophthalmology, Kyushu University, Graduate School of Medical Sciences, Fukuoka, Japan
  • Yuki Kubo
    Ophthalmology, Kyushu University, Graduate School of Medical Sciences, Fukuoka, Japan
  • Takahito Nakama
    Ophthalmology, Kyushu University, Graduate School of Medical Sciences, Fukuoka, Japan
  • Masato Akiyama
    Ophthalmology, Kyushu University, Graduate School of Medical Sciences, Fukuoka, Japan
    Ocular Pathology and Imaging Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
  • Mitsuru Arima
    Ophthalmology, Kyushu University, Graduate School of Medical Sciences, Fukuoka, Japan
  • Shoji Notomi
    Ophthalmology, Kyushu University, Graduate School of Medical Sciences, Fukuoka, Japan
  • Yusuke Murakami
    Ophthalmology, Kyushu University, Graduate School of Medical Sciences, Fukuoka, Japan
  • Toshio Hisatomi
    Ophthalmology, Fukuoka University Chikushi Hospital, Chikushi, Japan
  • Shintaro Nakao
    Ophthalmology, Kyushu University, Graduate School of Medical Sciences, Fukuoka, Japan
  • Shigeo Yoshida
    Ophthalmology, Kurume University School of Medicine, Kurume, Japan
  • Koh-hei Sonoda
    Ophthalmology, Kyushu University, Graduate School of Medical Sciences, Fukuoka, Japan
  • Footnotes
    Commercial Relationships   Kenichiro Mori, None; Keijiro Ishikawa, None; Iori Wada, None; Yuki Kubo, None; Takahito Nakama, None; Masato Akiyama, None; Mitsuru Arima, None; Shoji Notomi, None; Yusuke Murakami, None; Toshio Hisatomi, None; Shintaro Nakao, None; Shigeo Yoshida, None; Koh-hei Sonoda, None
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 243. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Kenichiro Mori, Keijiro Ishikawa, Iori Wada, Yuki Kubo, Takahito Nakama, Masato Akiyama, Mitsuru Arima, Shoji Notomi, Yusuke Murakami, Toshio Hisatomi, Shintaro Nakao, Shigeo Yoshida, Koh-hei Sonoda; Downregulation of TNFRSF10A promotes RPE cell death via PKC deactivation. Invest. Ophthalmol. Vis. Sci. 2021;62(8):243.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : We previously reported that downregulation of TNFRSF10A, a susceptibility gene for age-related macular degeneration (AMD) and central serous chorioretinopathy (CSC), can cause retinal pigment epithelium (RPE) cell death in vitro and Tnfrsf10knockout mice. In this study, we investigated the molecular mechanism of RPE cell death associated with TNFRSF10A downregulation.

Methods : All in vitro experiments were performed using primary fetal human RPE (hRPE) cells. After transfection with siRNA targeting TNFRSF10A, we treated the cells with or without different cell death inhibitors or phorbol 12-myristate 13-acetate (PMA),a PKC activator, and cell viability change were evaluated by Cell Counting Kit-8 and staining with FITC-conjugated annexin V/PI followed by flow cytometric analysis. Realtime RT-PCR was performed to examine the transcriptional levels of cell cycle regulatory proteins in the cells.

Results : Knockdown of TNFRSF10A by siRNA significantly reduced RPE cell viability and increased the percentages of annexin V+/PI- early apoptotic cells (P<0.0001). PMA inhibit the cell death induced by TNFRSF10A knockdown, while apoptosis inhibitors, a necroptosis inhibitor, a feroptosis inhibitor and a pyroptosis inhibitor did not. TNFRSF10A knockdown changed mRNA levels of cell cycle regulatory proteins, downregulation of cyclinA1 (P<0.05) and upregulation of p27 (P<0.005), which were reversed by PMA treatment.

Conclusions : TNFRSF10A downregulation may contribute to the pathogenesis of AMD and CSC by promoting RPE cell death via PKC pathway.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×